131 related articles for article (PubMed ID: 9009096)
1. Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation.
Boer J; Mahmoud H; Raimondi S; Grosveld G; Krance R
Leukemia; 1997 Feb; 11(2):299-300. PubMed ID: 9009096
[No Abstract] [Full Text] [Related]
2. Quantification of DEK-CAN fusion transcript by real-time reverse transcription polymerase reaction in patients with t(6;9) acute myeloid leukemia.
Tobal K; Frost L; Liu Yin JA
Haematologica; 2004 Oct; 89(10):1267-9. PubMed ID: 15477217
[TBL] [Abstract][Full Text] [Related]
3. Localized relapse in bone marrow in a posttransplantation patient with t(6;9) acute myeloid leukemia.
Maeda T; Kosugi S; Ujiie H; Osumi K; Fukui T; Yoshida H; Kashiwagi H; Ishikawa J; Tomiyama Y; Matsuzawa Y
Int J Hematol; 2003 Jun; 77(5):522-5. PubMed ID: 12841393
[TBL] [Abstract][Full Text] [Related]
4. [The detection of minimal residual disease by DEK/CAN chimeric m-RNA in a case of AML M2 with translocation t(6;9) (p23;q34) after chemotherapy and peripheral blood stem cell transplantation].
Toyosawa M; Shinohara K; Ariyoshi K; Ando T; Kobayashi M; Hikiji K
Rinsho Ketsueki; 1997 Jan; 38(1):33-40. PubMed ID: 9028159
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission.
Díaz-Beyá M; Labopin M; Maertens J; Aljurf M; Passweg J; Dietrich B; Schouten H; Socié G; Schaap N; Schwerdtfeger R; Volin L; Michallet M; Polge E; Sierra J; Mohty M; Esteve J; Nagler A;
Br J Haematol; 2020 Jun; 189(5):920-925. PubMed ID: 32020596
[TBL] [Abstract][Full Text] [Related]
6. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
Kong XT; Ida K; Ichikawa H; Shimizu K; Ohki M; Maseki N; Kaneko Y; Sako M; Kobayashi Y; Tojou A; Miura I; Kakuda H; Funabiki T; Horibe K; Hamaguchi H; Akiyama Y; Bessho F; Yanagisawa M; Hayashi Y
Blood; 1997 Aug; 90(3):1192-9. PubMed ID: 9242552
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion.
Oliveira JL; Kumar R; Khan SP; Law ME; Erickson-Johnson M; Oliveira AM; Ketterling RP; Dogan A
Pediatr Blood Cancer; 2011 Mar; 56(3):467-9. PubMed ID: 21225930
[TBL] [Abstract][Full Text] [Related]
8. Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene.
von Lindern M; Fornerod M; Soekarman N; van Baal S; Jaegle M; Hagemeijer A; Bootsma D; Grosveld G
Baillieres Clin Haematol; 1992 Oct; 5(4):857-79. PubMed ID: 1308167
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases.
Fang H; Yabe M; Zhang X; Kim Y; Wu X; Wei P; Chi S; Zheng L; Garcia-Manero G; Shao L; Yuan J; Shen Y; Zheng G; Tang G; Wang W; Loghavi S; Shen Q; Yuan Y; He R; Chen D; Medeiros LJ; Hu S
Mod Pathol; 2021 Jun; 34(6):1143-1152. PubMed ID: 33558656
[TBL] [Abstract][Full Text] [Related]
10. [Acute myeloblastic leukemia without maturation (AML-M1) with basophilic elements and associated with translocation t(6;9)].
Dimicoli S; Fohlen-Walter A; Mansuy L; Buisine J; Grégoire MJ; Lecompte T; Bordigoni P; Jonveaux P; Lesesve JF
Ann Biol Clin (Paris); 2003; 61(3):352-7. PubMed ID: 12805015
[TBL] [Abstract][Full Text] [Related]
11. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
Kusec R; Laczika K; Knöbl P; Friedl J; Greinix H; Kahls P; Linkesch W; Schwarzinger I; Mitterbauer G; Purtscher B
Leukemia; 1994 May; 8(5):735-9. PubMed ID: 7514242
[TBL] [Abstract][Full Text] [Related]
12. t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.
Sandahl JD; Coenen EA; Forestier E; Harbott J; Johansson B; Kerndrup G; Adachi S; Auvrignon A; Beverloo HB; Cayuela JM; Chilton L; Fornerod M; de Haas V; Harrison CJ; Inaba H; Kaspers GJ; Liang DC; Locatelli F; Masetti R; Perot C; Raimondi SC; Reinhardt K; Tomizawa D; von Neuhoff N; Zecca M; Zwaan CM; van den Heuvel-Eibrink MM; Hasle H
Haematologica; 2014 May; 99(5):865-72. PubMed ID: 24441146
[TBL] [Abstract][Full Text] [Related]
13. Treatment of relapsed acute myelogeneous leukaemia with MLL/AF 6 fusion after stem cell transplantation by intensive reinduction followed by adoptive immunotherapy.
Schuster FR; Führer M; Woessmann W; Reiter A; Harbott J; Viehmann S; Borkhardt A
Leukemia; 2005 Jul; 19(7):1273-4; author reply 1275-6. PubMed ID: 15902291
[No Abstract] [Full Text] [Related]
14. The kinetics of relapse in DEK-NUP214-positive acute myeloid leukemia patients.
Ommen HB; Touzart A; MacIntyre E; Kern W; Haferlach T; Haferlach C; Tobal K; Hokland P; Schnittger S
Eur J Haematol; 2015 Nov; 95(5):436-41. PubMed ID: 25605311
[TBL] [Abstract][Full Text] [Related]
15. t(6;9)(p23;q34.1) acute myeloid leukaemia with cup-like blasts.
Bories C; Boyer T
Br J Haematol; 2018 Jul; 182(1):9. PubMed ID: 29767433
[No Abstract] [Full Text] [Related]
16. Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
Innes A; May PC; Pavlů J; Bain BJ
Am J Hematol; 2012 Apr; 87(4):412. PubMed ID: 21953481
[No Abstract] [Full Text] [Related]
17. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplant.
Ishiyama K; Takami A; Kanda Y; Nakao S; Hidaka M; Maeda T; Naoe T; Taniguchi S; Kawa K; Nagamura T; Tabuchi K; Atsuta Y; Sakamaki H
Leukemia; 2012 Jun; 26(6):1416-9. PubMed ID: 22157737
[No Abstract] [Full Text] [Related]
19. Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
Zhu HH; Jiang H; Jiang Q; Jia JS; Qin YZ; Huang XJ
Leuk Res; 2016 May; 44():40-4. PubMed ID: 26994850
[TBL] [Abstract][Full Text] [Related]
20. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
Brown SA; Czepulkowski B; Ireland R
Leuk Res; 1996; 20(11-12):987-8. PubMed ID: 9009258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
